Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Extends Conflict Disclosure Policy To All Advisory Panel Members

Nov 12 2007

• By Brian Marson

Related Content

Draft Conflict Of Interest Policy Affects Status Of Many FDA Cmte. Members

Mar 26 2007

FDA Aims To Boost Transparency Through Earlier Release Of Panel Materials

Mar 05 2007

‘High Dollar’ Conflicts Should Nullify FDA Advisory Panelists – Public Citizen

May 01 2006

Additional Topics

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window